ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GDR Genedrive Plc

4.10
0.225 (5.81%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.225 5.81% 4.10 4.05 4.15 4.275 3.825 3.88 29,115,559 16:25:52
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0095 -4.32 21.05M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 3.88p. Over the last year, Genedrive shares have traded in a share price range of 1.425p to 15.00p.

Genedrive currently has 543,141,481 shares in issue. The market capitalisation of Genedrive is £21.05 million. Genedrive has a price to earnings ratio (PE ratio) of -4.32.

Genedrive Share Discussion Threads

Showing 28826 to 28839 of 28850 messages
Chat Pages: 1154  1153  1152  1151  1150  1149  1148  1147  1146  1145  1144  1143  Older
DateSubjectAuthorDiscuss
27/7/2024
11:29
Thought I'd check in as Z1co seems obsessed with me, following me around other threads like a bad smell. You have to think that if he didn't have such toxic traits then maybe he wouldn't attract the dross to trash anything he does. Also, King Z1co, really? Are you 12?I don't feel the need for validation on my positions, some obviously do; I also see plenty of projection going on when my integrity on positions questioned, you have to ask those posters why?Anyway, pleasant weekend all, and successful trading for the coming week.Regards the floorBeeks of Arrhythmia
premium beeks
27/7/2024
08:44
Watching MM's playing their games yesterday and how they controlled the price , you have to admit they are good at their job.

It was so obvious they wanted to accumulate as much SHARES as they can get from traders ahead of the expected surge in volume this week.

Right until the close they were giving traders well above the BID for those that wanted to sell and a lot of the times even higher the MID price.

And yet they were limiting the amount of buying , many times it was NT to get a quote for just 25,000 shares.

On one occasion when the BID was at 4.10p i was being quoted to SELL 1,000,000 @ 4.15p ie the mid price.

Looking forward to the coming week with great anticipation, the NICE publication is all set for Wednesday , their comments about CYP2C19 Test over the last 12 months strongly indicate that they will APPROVE the test.

Wednesday will be an HUGE volume day and likely to exceed 0.5 Billion.

z1co
26/7/2024
17:38
With only 2 trading days left price will obviously keep rising ,it's not even 4.5p yet
z1co
26/7/2024
17:05
I love me a quick profit 🤑

Nice 4.10 finish today, very much expecting 5p Monday.
Exciting times. 👍

halland75
26/7/2024
16:38
The last paragraph is of significant importance if NICE were not going to approve CYP2C19 ID Test then why would they say quote:

"NICE is working in partnership with colleagues at NHS England and NHS Improvement, to develop a resource to support the implementation which will publish alongside the final guidance."

z1co
26/7/2024
16:37
For Professor Aim

Read the last paragraph and as a professor i'm sure you will understand what it means:

In addition to being dominant in cost effectiveness models, NICE recommends the Genedrive® as the point-of-care platform of choice for CYP2C19 genotyping strategies in the NHS. The decision was based on several differentiating features of the Genedrive® technology;

1) its greater coverage of genetic variants compared to the other point-of-care system assessed, permitting increased equitable access to healthcare across ethnic populations

2) no requirement for cold-chain storage logistics

3) its ability to integrate with patient electronic healthcare systems.

The UK's National Institute for Health and Care Excellence ("NICE") has recommended in draft guidance, that the Genedrive® CYP2C19-ID test should be used as the point-of-care test of choice in the NHS before clopidogrel administration in the management of IS and TIA patient

Resolution has now concluded, so we plan to publish as soon as we can. NICE is working in partnership with colleagues at NHS England and NHS Improvement, to develop a resource to support the implementation which will publish alongside the final guidance

z1co
26/7/2024
16:33
PA

Market has now closed but keep trying ,,, hahahahah

z1co
26/7/2024
16:32
There we have it folks closed @ 4.10p and above the 4p resistance.

Ready to march towards the 5p from Monday.

z1co
26/7/2024
16:30
Glad i sold now looks very bad weak even. Peel still have lots to sellBad news and its 1.5p again
professoraim
26/7/2024
16:29
Worried here think people should sell now
professoraim
26/7/2024
16:26
Worried if nice is not approved will this crash
professoraim
26/7/2024
16:24
Ahhhh bless BIG DADDY

I'm still waiting for your reply!

z1co
26/7/2024
16:22
Will we see some large buys after the close?

Seems like the MM’s have been controlling this all day.

daddy warbucks
26/7/2024
16:22
MM's need all they can get for the expected surge in volume next week
z1co
Chat Pages: 1154  1153  1152  1151  1150  1149  1148  1147  1146  1145  1144  1143  Older

Your Recent History

Delayed Upgrade Clock